View Single Post
Old 06-01-2019   #1190
florida80
R11 Độc Cô Cầu Bại
 
florida80's Avatar
 
Join Date: Aug 2007
Posts: 113,793
Thanks: 7,446
Thanked 47,149 Times in 13,135 Posts
Mentioned: 1 Post(s)
Tagged: 0 Thread(s)
Quoted: 511 Post(s)
Rep Power: 161
florida80 Reputation Uy Tín Level 11florida80 Reputation Uy Tín Level 11florida80 Reputation Uy Tín Level 11florida80 Reputation Uy Tín Level 11
florida80 Reputation Uy Tín Level 11florida80 Reputation Uy Tín Level 11florida80 Reputation Uy Tín Level 11florida80 Reputation Uy Tín Level 11florida80 Reputation Uy Tín Level 11florida80 Reputation Uy Tín Level 11florida80 Reputation Uy Tín Level 11florida80 Reputation Uy Tín Level 11florida80 Reputation Uy Tín Level 11florida80 Reputation Uy Tín Level 11florida80 Reputation Uy Tín Level 11florida80 Reputation Uy Tín Level 11florida80 Reputation Uy Tín Level 11florida80 Reputation Uy Tín Level 11florida80 Reputation Uy Tín Level 11florida80 Reputation Uy Tín Level 11florida80 Reputation Uy Tín Level 11
Default

What’s the right treatment plan for imbalances in pharmacist workforce supply and demand?

Thomas E. Menighan




, BSPharm, MBA, ScD (Hon), FAPhA (Executive Vice President and CEO, APhA)



























Imbalances between workforce supply and demand are notoriously difficult to resolve. Market corrections can take decades to work themselves out, and leaving the market to self-correct doesn’t help those who are suffering today. APhA aims to tackle the problem, yet this stuff is hard! Still, our proactive efforts have opened some potential avenues to progress.

We’re making headway, but just as market and practice changes took time, so will solutions. Since June 2017, APhA’s leadership has targeted the challenges that affect the well-being and resiliency of pharmacists and pharmacy personnel, and our efforts picked up through the discussions of our 2018 House of Delegates. The complexities we’re facing include workforce changes, health care and societal economics and their associated pressures, payer policies, and provider status. It isn’t as simple as “too many schools”!

We’re still working on the profession’s “big picture issues,” including provider status and other regulatory, financial, and legislative remedies. We’re also tackling these short-term issues:
■Payment policies that harm the sustainability of pharmacy practices and their ability to safely provide services to patients.

■Pharmacy safety concerns that are very real and must be addressed.

■Workplace conditions that make many frontline pharmacists feel like they’re in an assembly line. System efficiencies, use of technology, and reductions in administrative burdens can reduce practitioner pain points and allow enhanced focus on patient care.

■Concerns about retaliation against staff who speak up. Retaliation is a violation of the most basic tenets of patient safety systems. At APhA2018 and APhA2019, the APhA House of Delegates adopted a policy officially opposing retaliation and expressing support for systems that allow pharmacists to share their patient safety concerns without fear of losing their job or facing sanctions.

■Pharmacist and pharmacy personnel well-being. Self-care and resilience are essential for any health care professional, and pharmacist well-being is at the center of a major new APhA initiative we’re getting off the ground. Our November 2018 statement on pharmacist and pharmacy personnel well-being and resilience identifies important parts of the equation, such as employer and workplace issues, payment policies, pharmacist recognition, and system issues.



We will convene a consensus conference in July 2019 to facilitate collaborative, respectful dialogue among employers and pharmacy staff, educators, regulators, and policymakers that balances their respective needs and objectives. Stay tuned to learn more about the outcomes of our July 2019 consensus conference.
florida80_is_offline  
 
Page generated in 0.04295 seconds with 9 queries